IS8509A - Ný 2-heteróarýl-setin bensímídasól afleiða - Google Patents

Ný 2-heteróarýl-setin bensímídasól afleiða

Info

Publication number
IS8509A
IS8509A IS8509A IS8509A IS8509A IS 8509 A IS8509 A IS 8509A IS 8509 A IS8509 A IS 8509A IS 8509 A IS8509 A IS 8509A IS 8509 A IS8509 A IS 8509A
Authority
IS
Iceland
Prior art keywords
heteroaryl
new
benzimidazole derivative
substituted benzimidazole
substituted
Prior art date
Application number
IS8509A
Other languages
English (en)
Icelandic (is)
Inventor
Nonoshita Katsumasa
Ogino Yoshio
Ishikawa Makoto
Sakai Fumiko
Nakashima Hiroshi
Nagae Yoshikazu
Tsukahara Daisuke
Arakawa Keisuke
Nishimura Teruyuki
Eiki Junichi
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of IS8509A publication Critical patent/IS8509A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS8509A 2003-12-29 2006-06-15 Ný 2-heteróarýl-setin bensímídasól afleiða IS8509A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003436992 2003-12-29
JP2004235696 2004-08-13
PCT/JP2004/019843 WO2005063738A1 (ja) 2003-12-29 2004-12-28 新規2-へテロアリール置換ベンズイミダゾール誘導体

Publications (1)

Publication Number Publication Date
IS8509A true IS8509A (is) 2006-06-15

Family

ID=34742165

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8509A IS8509A (is) 2003-12-29 2006-06-15 Ný 2-heteróarýl-setin bensímídasól afleiða

Country Status (15)

Country Link
US (1) US7728025B2 (de)
EP (1) EP1702919B1 (de)
JP (1) JP4707560B2 (de)
KR (1) KR20060105872A (de)
AU (1) AU2004309287B2 (de)
BR (1) BRPI0418212A (de)
CA (1) CA2553160C (de)
EC (1) ECSP066682A (de)
IL (1) IL176451A0 (de)
IS (1) IS8509A (de)
MA (1) MA28336A1 (de)
NO (1) NO20063475L (de)
NZ (1) NZ548128A (de)
RU (1) RU2329261C2 (de)
WO (1) WO2005063738A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
CA2581619A1 (en) 2004-10-16 2006-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
AU2005301608B2 (en) * 2004-11-02 2012-09-13 Msd K.K. Aryloxy-substituted benzimidazole derivatives
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
BRPI0622262A2 (pt) 2005-07-09 2011-08-09 Astrazeneca Ab composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
JP5281287B2 (ja) * 2005-07-13 2013-09-04 Msd株式会社 ヘテロ環置換ベンズイミダゾール誘導体
JP2007063225A (ja) * 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
WO2007031739A1 (en) * 2005-09-16 2007-03-22 Astrazeneca Ab Heterobicyclic compounds as glucokinase activators
WO2007039177A2 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
US7625890B2 (en) 2005-11-10 2009-12-01 Smithkline Beecham Corp. Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors
EP1948614A2 (de) * 2005-11-18 2008-07-30 Takeda San Diego, Inc. Glucokinaseaktivatoren
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
ES2380683T3 (es) * 2005-12-15 2012-05-17 Astrazeneca Ab Difenil-éteres, -amidas, -sulfuros y - metanos sustituidos para el tratamiento de la enfermedad respiratoria
KR101332975B1 (ko) * 2006-01-23 2013-11-25 암젠 인크 오로라 키나제 조절제 및 사용 방법
US7560551B2 (en) 2006-01-23 2009-07-14 Amgen Inc. Aurora kinase modulators and method of use
TW200813039A (en) 2006-04-19 2008-03-16 Novartis Ag 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
JP5306818B2 (ja) * 2006-10-18 2013-10-02 武田薬品工業株式会社 縮合複素環化合物
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
TW200825060A (en) 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
WO2008075073A1 (en) 2006-12-21 2008-06-26 Astrazeneca Ab Novel crystalline compound useful as glk activator
WO2008136428A1 (ja) * 2007-04-27 2008-11-13 Takeda Pharmaceutical Company Limited 含窒素5員複素環化合物
ES2493593T3 (es) 2007-11-12 2014-09-12 Msd K.K. Derivado de heteroariloxi quinazolina
PT2239253E (pt) * 2008-02-06 2013-09-17 Daiichi Sankyo Co Ltd Novo derivado de fenilpirrole
RU2531354C2 (ru) 2008-04-28 2014-10-20 Янссен Фармацевтика Нв Бензоимидазолы как ингибиторы пролилгидроксилазы
WO2010015849A2 (en) 2008-08-04 2010-02-11 Astrazeneca Ab Therapeutic agents 414
AU2009280579A1 (en) * 2008-08-15 2010-02-18 Banyu Pharmaceutical Co.,Ltd. Acetyl pyrrolidinyl indole derivative
JP2012501295A (ja) * 2008-08-29 2012-01-19 Msd株式会社 オキソテトラヒドロフラン−2−イル−ベンズイミダゾール誘導体
JP5731978B2 (ja) * 2008-09-26 2015-06-10 インテリカイン, エルエルシー 複素環キナーゼ阻害剤
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
AR077328A1 (es) 2009-07-24 2011-08-17 Novartis Ag Derivados de oxazina y su uso en el tratamiento de trastornos neurologicos
CA2780128A1 (en) 2009-11-06 2011-05-12 P. Jeffrey Conn Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
MY159151A (en) * 2009-12-04 2016-12-15 Nissan Chemical Ind Ltd 2-pyridone compounds
MX2012006877A (es) * 2009-12-18 2012-08-31 Idenix Pharmaceuticals Inc Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
JP5600754B2 (ja) 2009-12-31 2014-10-01 ノバルティス アーゲー ピラジン誘導体および神経障害の処置におけるそれらの使用
MY150939A (en) 2010-07-13 2014-03-14 Novartis Ag Oxazine derivatives and their use in the treatment of neurological disorders
BR112013017779A2 (pt) 2011-01-12 2016-10-11 Novartis Ag derivados de oxazina e seu uso no tratamento de distúrbios neurológicos
BR112014009910B1 (pt) 2011-10-25 2020-06-30 Janssen Pharmaceutica N.V. sal di-hidrato de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico, composição farmacêuticae pomada tópica
EP3586835B1 (de) 2013-09-09 2023-11-22 Peloton Therapeutics, Inc. Pharmazeutische zusammensetzungen enthaltend arylether
WO2016145045A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Compositions for use in treating glioblastoma
US10155726B2 (en) 2015-03-11 2018-12-18 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
WO2016144825A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
US10278942B2 (en) 2015-03-11 2019-05-07 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
US10335388B2 (en) 2015-04-17 2019-07-02 Peloton Therapeutics, Inc. Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
AU2016348549B2 (en) 2015-11-02 2020-07-23 Janssen Pharmaceutica Nv [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound
CN109923116B (zh) 2016-11-02 2022-12-06 詹森药业有限公司 作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶衍生物
EA039102B1 (ru) 2016-11-02 2021-12-03 Янссен Фармацевтика Нв Соединения [1,2,4]триазоло[1,5-a]пиримидина в качестве ингибиторов pde2
CA3038913A1 (en) 2016-11-02 2018-05-11 Janssen Pharmaceutica Nv [1,2,4]triazolo[1,5-a]pyrimidine compounds as pde2 inhibitors
JP2024529298A (ja) 2021-07-09 2024-08-06 プレキシウム インコーポレイテッド Ikzf2を調節するアリール化合物及び医薬組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134354C (de) 1963-05-23
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
EP0726260A1 (de) 1995-02-08 1996-08-14 American Cyanamid Company Herbizide (1,2,4)Thiadiazole
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
WO1999037630A1 (en) * 1998-01-23 1999-07-29 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
JP2000026430A (ja) 1998-07-02 2000-01-25 Taisho Pharmaceut Co Ltd 2、5、6−置換ベンズイミダゾール化合物誘導体
EP1401831A1 (de) * 2001-07-03 2004-03-31 Chiron Corporation Indazol-benzimidazol-derivate als tyrosin- und serin/threonin-kinase-inhibitoren
DE10238002A1 (de) * 2002-08-20 2004-03-04 Merck Patent Gmbh Benzimidazolderivate
AR045414A1 (es) * 2003-02-13 2005-10-26 Banyu Pharma Co Ltd Derivados de 2 - piridincarboxamida y composiciones farmaceuticas que las contienen.
US7432287B2 (en) * 2003-02-26 2008-10-07 Banyu Pharmeceutical Co., Ltd. Heteroarylcarbamoylbenzene derivative
AU2005301608B2 (en) * 2004-11-02 2012-09-13 Msd K.K. Aryloxy-substituted benzimidazole derivatives
TW200745031A (en) * 2005-10-13 2007-12-16 Merck & Co Inc Acyl indoles, compositions containing such compounds and methods of use
TW200821284A (en) * 2006-10-03 2008-05-16 Merck & Co Inc Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Also Published As

Publication number Publication date
EP1702919A4 (de) 2008-11-12
US7728025B2 (en) 2010-06-01
RU2006127420A (ru) 2008-02-10
JP4707560B2 (ja) 2011-06-22
IL176451A0 (en) 2006-10-05
MA28336A1 (fr) 2006-12-01
WO2005063738A1 (ja) 2005-07-14
AU2004309287A1 (en) 2005-07-14
CA2553160A1 (en) 2005-07-14
ECSP066682A (es) 2006-10-25
CA2553160C (en) 2010-09-28
JPWO2005063738A1 (ja) 2007-07-19
AU2004309287B2 (en) 2008-07-31
NZ548128A (en) 2010-05-28
EP1702919A1 (de) 2006-09-20
BRPI0418212A (pt) 2007-04-27
KR20060105872A (ko) 2006-10-11
NO20063475L (no) 2006-09-28
US20080070928A1 (en) 2008-03-20
RU2329261C2 (ru) 2008-07-20
EP1702919B1 (de) 2012-05-30

Similar Documents

Publication Publication Date Title
IS8509A (is) Ný 2-heteróarýl-setin bensímídasól afleiða
IS7667A (is) Nýjar bensimídazólafleiður
IS2656B (is) Nýjar besímídasólafleiður
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
NO20054136D0 (no) Imidazol-4-yl-etynyl-pyridin-derivater
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
ATE420066T1 (de) Amidoacetonitrilderivate
DE602004025020D1 (de) Baumaschine
ATE352550T1 (de) Chinazolinderivate
ATE386518T1 (de) Benzimidazolderivate
IS8364A (is) N-þíasól-2-ýl-bensamíð afleiður
DE602004008699D1 (de) Spitzenklöppelmaschine
IS8045A (is) Púrín-6-ón-afleiður
DE50304148D1 (de) Handstichs gemaschine
ATE457299T1 (de) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ
ATE449064T1 (de) Amidoacetonitrilderivate
DE112004001791D2 (de) Bohrkopf
DE10390324D2 (de) Geradeaus-Ziehmaschine
ITMI20030161A1 (it) Lattometro a passaggio diretto
SE0303421L (sv) En list
DE50304664D1 (de) Handstichs gemaschine
ATE516273T1 (de) Insektizides spiroindanderivat
NO20030740D0 (no) Phenyl-derivative A
SE0301104D0 (sv) A new combination
SE0301105D0 (sv) A new combination